drugset / Trial / NCT02989727
Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine if patients with melancholic bipolar II depression are more responsive to lamotrigine than patients with non-melancholic bipolar II depression. To do this, the investigators will re-analyze a previous clinical trial that evaluated lamotrigine as a treatment for bipolar II depression (GSK-SCA100223; NCT00274677).
Timeline
- Start
- 2003-11
- Primary completion
- 2005-08
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lamotrigine | Small molecule | 200 mg | — |